INTRODUCTION
observation from our SHAPE data is that we do not only observe a reactivity modification for 136 As or Us. . Nucleotides in red are significantly more reactive with m 6 A whereas those in blues are significantly less reactive (p-value < 0.05 and reactivity difference > 0.4). Nucleotides in white are of equivalent reactivity. Sites where the reactivity could not be determined are depicted in grey. The histogram shows the reactivity difference between 0% m 6 A 5'-UTR and 100% m 6 A 5'-UTR (lower). Blue and red bars highlight nucleotides with a significantly lower or higher reactivity in the 100% m6A RNA than in the 0% m6A RNA (p-value < 0.05 and reactivity difference > 0.4), respectively. Significative differences that are below the threshold of 0.4 are indicated in black. b, Fraction of dimers determined by electromobility shift assay for different concentrations of in vitro transcribed 5'-UTR (1 µM, 0.5 µM, 0.25 µM, 127 nM, 65 nM, 33 nM, 18 nM, 2 nM) harboring either 0% of m 6 A (grey) or 100% of m 6 A (red) with the dissociation constants obtained from the data points (see Methods for details). 
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Nucleotides in white are of equivalent reactivity. Sites where the reactivity could not be determined are depicted in grey. The 143 histogram shows the reactivity difference between 0% m 6 A 5'-UTR and 100% m 6 A 5'-UTR (lower). Blue and red bars 144 highlight nucleotides with a significantly lower or higher reactivity in the 100% m6A RNA than in the 0% m6A RNA (p- Moreover, although all adenosines were methylated in the m 6 A-5'-UTR RNA only local 150 reactivity changes, often clustered, were observed suggesting that the presence of m 6 A 151 influences the folding of specific domains or motifs within the 5´-UTR. The presence of m 6 A 152 is predicted and has been observed to destabilize A-U pairings embedded in helical regions. 153 This is mostly in agreement with the destabilizations (increase in reactivity) that are often 154 observed for As, Us or in nucleotides in close proximity with proposed A-U base pairs. In 155 particular, this could explain the reactivity enhancement within the poly-A stem, which is 156 likely to be globally destabilized by m 6 A. However, none of the other nucleotides for which 157 we observe a reactivity increase is involved or are close to A-U pairings and most of them are 158 not even predicted to be base paired in most of the published models. In contrast, m 6 A has 159 been shown to stabilize A-U pairings when preceded in 5' by a bulged nucleotide. This does 160 not offer a rationale for any of the reactivity drop we observe which are mostly predicted to 161 be in single strand regions thus, suggesting that m 6 A modulates a higher order structure 162 and/or tertiary pairings yet to be identified. This prompted us to monitor dimerization of the 163 5'-UTR and m 6 A-5´-UTR in vitro. We observed that the presence of m 6 A reduces but not 164 abolish the efficiency of dimerization (Fig. 1b ). The structure of the HIV-1 full-length RNA 165 dimer is still poorly defined and a matter of debate, thus the dimerization deficiency observed 166 does not provide a straightforward explanation for all the alterations of the SHAPE profile but 167 could reveal unknown rearrangements. 168
Together, these data indicate that the presence of m 6 A may play an important role in the 169 folding and dimerization of the 5´-UTR and prompted us to study this feature in a cellular 170 context. 171
172
The presence of m 6 A within the full-length RNA favors Gag synthesis but interferes with 173 packaging 174
In order to study the role of m 6 A on the cytoplasmic fate of the full-length RNA during viral 175 replication, we first determined the effects of METTL3/14 overexpression on Gag and full-176 length RNA levels obtained from cell extracts and purified viral particles (see scheme in 177 Supplementary Fig. 2a ). m 6 A-RIP analysis from METTL3/14 overexpressing cells showed an 178 increase in the m 6 A/A ratio of the full-length RNA compared to the control indicating that the 179 viral transcript is hypermethylated under these experimental conditions ( Supplementary Fig.  180 2b). Consistent with the positive role of m 6 A on Gag synthesis previously described 20-22 , we 181 observed that increased methylation of the full-length RNA by METTL3/14 overexpression 182 results in increased levels of Gag and its processing products with minor effects on the intracellular levels of the full-length RNA ( Fig. 2a ). Quantification of viral particles produced 184 from the same cells revealed a slight increase in Gag levels (as judged by anti-CAp24 ELISA) 185 from METTL3/14 overexpressing cells, which could be attributed to the increased Gag 186 synthesis observed ( Fig. 2b) . HEK293T cells were transfected with pNL4.3 and pCMV-VSVg together with pCDNA-Flag-METTL3 and pCDNA-Flag-METTL14 or pCDNA-d2EGFP as a control. a, At 24 hpt cells extracts were used to detect Gag, Flag-METTL3 and Flag-METTL14 by Western blot. GAPDH was used as a loading control (left panel). In parallel, cells extracts were used to perform RNA extraction and the full-length RNA was quantified by RT-qPCR (right panel). Intracellular full-length RNA was normalized to the control (arbitrary set to 100%) and presented as the mean +/-SD of three independent experiments (*P<0.05, t-test). b, Supernatants from cell cultures in (a) were filtered and viral particles were purified by ultracentrifugation. The level of CAp24 was quantified by an anti-CAp24 ELISA. The level of CAp24 was normalized to the control (arbitrary set to 100%) and presented as the mean +/-SD of three independent experiments (n.s; nonsignificant, t-test). c, Viral particles purified from (b) were used to perform RNA extraction and the packaged full-length RNA from CAp24 equivalents was quantified by RT-qPCR. Packaged full-length RNA was normalized to the control (arbitrary set to 100%) and presented as the mean +/-SD of three independent experiments (***P<0.001, t-test). d, HeLa cells were transfected with pNL4.3, pCMV-VSVg and pCDNA-Flag-METTL3. At 24 hpt, the interaction between the full-length RNA and the Flag-tagged METTL3 was analyzed by ISH-PLA as described in the Methods section. Red dots indicate the interactions between the full-length RNA and the METTL3. Scale bar 10 µm. A quantification of the red dots in the nucleus (co-localizing with the DAPI staining) and the cytoplasm of 14 cells is presented on the right (****P<0.0001, Mann-Whitney test). 
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Then, we quantified the full-length RNA from equal amounts of viral particles and observed 207 that viral particles produced under METTL3/14 overexpression contain around 3-fold less 208 packaged gRNA indicating that hypermethylation of the full-length RNA impedes its 209 packaging into nascent particles ( Fig. 2c ). We were not able to observe a similar effect of 210 murine METTL3/14 overexpression on the simple retrovirus MLV, which was shown two 211 segregate their full-length RNA into two specialized populations for translation and 212
packaging further suggesting that MLV and HIV-1 might evolved diverse mechanisms for the 213 cytoplasmic sorting of their full-length RNA ( Supplementary Fig. 2c ). 214
Since results presented above indicate that m 6 A deposition by METTL3/14 affects the 215 cytoplasmic fate of the full-length RNA, we wanted to investigate where within the cell the 216 m 6 A writer complex modifies the viral RNA. For this, we analyzed the interaction between 217 the full-length RNA and METTL3 by in situ hybridization coupled to the proximity ligation 218 assay (ISH-PLA) 24 . Confocal microscopy analyses revealed a predominant interaction within 219 the nucleus, which suggests that the full-length RNA must be methylated in the nucleus and 220 reach the cytoplasm in a methylated form ( Fig. 2d and Supplementary Fig. 2d ). 221
Together, these data suggest that nuclear methylation of the HIV-1 full-length RNA by 222 METTL3/14 favors its use as mRNA for Gag synthesis but interferes with its incorporation 223 into viral particles. 224 225
Methylation of A 198 and A 242 within the 5´-UTR interferes with HIV-1 full-length RNA 226 packaging 227
From data presented above, it seems that the presence of m 6 A interferes with the function of 228 the HIV-1 full-length RNA as gRNA. Thus, to gain further insights into this regulation, we 229 employed the m 6 A-seq strategy to determine the m 6 A patterns of the intracellular and viral 230 particle-associated HIV-1 full-length RNA. In agreement with previous data reported for the 231
NL4.3 and LAI.2 strains in T-lymphocytes and HEK293T cells 20-22 , we identified m 6 A peaks 232
mainly at the 5´-UTR and a cluster of peaks at the 3´ end of the intracellular full-length RNA 233 ( Fig. 3a , see intracellular full-length RNA). Interestingly, we observed that the full-length 234
RNA from purified viral particles maintains the m 6 A peak at the 3´-UTR but lacks the m 6 A 235 peak at the 5´-UTR. This observation together with data from Fig. 2c suggests that the 236 presence of m 6 A at the 5´-UTR interferes with the incorporation of the full-length RNA into 237 viral particles ( Fig. 3a , see packaged full-length RNA). Of note, this difference in the 238 methylation patterns between intracellular and packaged RNA was not observed in the host 239 7SL RNA, which is also packaged at high levels into HIV-1 particles 25 , indicating a very 240 specific effect of m 6 A on full-length RNA packaging ( Supplementary Fig. 3a ). These data 241 strongly suggest that full-length RNA molecules lacking m 6 A at the 5´-UTR are primarily 242 selected by Gag as gRNA to be incorporated into viral particles. 243
A bioinformatic prediction of the potentially methylated residues within the 5-UTR of the 244 NL4.3 strain identified A 198 and A 242 in a very favorable methylation context (Supplementary 245 Fig. 3b ). Both residues are contained within the m 6 A peak we have identified within the 5´-246 UTR of the intracellular full-length RNA ( Supplementary Fig. 3c ) and were also identified in 247 previous m 6 A-seq data obtained from T-lymphocytes and HEK293T cells 20, 22 . Thus, we 248 deleted A 198 , A 242 or both from the NL4.3 provirus in order to determine the role of these 249 adenosine residues on the m 6 A-mediated regulation of full-length RNA packaging. We 250 observed that ΔA 198 and ΔA 242 single mutant proviruses were slightly resistant to the effects 251 of METTL3/14 overexpression on full-length RNA packaging ( Supplementary Fig. 3d ). 252
However, the ΔA 198 /ΔA 242 double mutant provirus was refractory to the positive effects of 253 METTL3/14 overexpression on Gag synthesis and the negative effects on full-length RNA 254 packaging observed with the wild type provirus indicating that A 198 and A 242 are key residues 255 involved in this m 6 A-mediated regulation ( Fig. 3b and Supplementary Fig. 3e ). Next, we 256 sought to investigate the role of A 198 and A 242 on HIV-1 full-length RNA metabolism. A 257 comparison between wild type and the ΔA 198 /A 242 provirus showed that the double mutant 258 virus accumulates more intracellular Gag but releases significantly less viral particles ( Fig. 3c  259 and Supplementary Fig. 3f ). Moreover, quantification of the full-length RNA from equal 260 amounts of viral particles revealed a defect in packaging in the ΔA 198 /A 242 double mutant 261 provirus thus, confirming the critical relevance of these two adenosine residues for the 262 incorporation of the HIV-1 full-length RNA into viral particles (Fig. 3c ). An analysis of 890 263 sequences from the HIV database (www.hiv.lanl.gov) indicate that A 198 and A 242 are highly 264 conserved within the 5´-UTR of isolates suggesting that this epitranscriptomic regulation 265 must be a common feature of different HIV-1 subtypes including the highly prevalent 266 subtypes C and B as well as circulating recombinant forms ( Fig. 3d and Supplementary Fig.  267 3g). Taking together, these results indicate that the HIV-1 full-length RNA may exist as two 268 different populations that differ at least in the m 6 A residues present within the 5´-UTR. Only Then, we sought to determine whether this m 6 A-mediated regulation of full-length RNA 290 packaging was a dynamic process. This was important considering that the reversible nature 291 of adenosine methylation in cellular mRNA has been challenged 26 . For this, we 292 overexpressed the RNA demethylase FTO and the analysis of the m 6 A/A ratio of the full-293 length RNA in control and FTO overexpressing cells revealed that the viral RNA is indeed a 294 substrate for this m 6 A eraser ( Supplementary Fig. 4a ). Consistent with a positive role of m 6 A 295 on Gag synthesis, we observed that FTO-induced demethylation of the full-length RNA 296 results in a reduction of Gag levels despite a slight increase in intracellular full-length RNA 297 levels (Fig. 4a ). We also observed minimal changes in the CAp24 levels from purified viral 298 particles produced under RNA demethylation conditions (Fig. 4b ). However and in agreement 299 with a negative role of m 6 A on full-length RNA packaging, we observed that viral particles 300 produced from FTO overexpressing cells contain around 3-fold more packaged gRNA 301 compared to the control (Fig. 4c ). It should be mentioned that we were not able to observe 302 similar results with the RNA demethylase ALKBH5 suggesting that full-length RNA 303 demethylation by FTO is important for packaging ( Supplementary Fig. 4b) . 304
Considering that m 6 A demethylation favors full-length RNA packaging, we wanted to know 305 where within the cell the viral RNA became demethylated by FTO. For this, we analyzed the 306 interaction of the between the full-length RNA and FTO in cells by ISH-PLA but despite 307 several attempts, we were not able to detect a direct interaction regardless all the components 308 were correctly expressed within the cells ( Supplementary Fig. 4c ). This observation suggests 309 that either there is no a massive interaction between the full-length RNA and FTO or that such 310 interactions occurs very transiently (or at very low rates) being below the detection limit of 311 our ISH-PLA strategy. 312
The lack of a detectable interaction between the full-length RNA and FTO prompted us to 313 investigate whether Gag could interact with FTO and drive full-length RNA demethylation. In 314 order to test this possibility, we employed the proximity ligation assay (PLA) and observed 315 that Gag and FTO indeed form complexes in cells (Fig. 4d ). Interestingly, quantification of 316 the dots per cell localizing with the nuclear staining as well as 3D reconstitutions of 317
representative images indicate that Gag and FTO mostly associates within the nucleus (Figs. 318 4e and 4f). Indeed, we observed that FTO overexpression increases the nuclear localization 319 of Gag ( Supplementary Fig. 4d ). 320 
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From these results, it was tempting to speculate that the full-length RNA is methylated within 345 the nucleus by METLL3/14 and Gag interacts with FTO in the nucleus to drive demethylation 346 of the full-length RNA molecules that will be incorporated into assembling viral particles. 347
Thus, we analyzed the m 6 A content of the full-length RNA in the presence or absence of Gag 348 by using the wild type NL4.3 provirus and a mutant provirus containing premature stops 349 codons that abolish Gag synthesis (GagStop provirus). Compared to the wild type full-length 350 RNA, the level of m 6 A increases when Gag is absent and is restored or even decreased when 351 the Gag protein was expressed in trans indicating that Gag regulates the methylation status of 352 the full-length RNA (Fig. 4g) . 353
Together, these results strongly indicate that the FTO-mediated demethylation is required for 354 full-length RNA packaging in a process supported by the Gag precursor. 355
356

Inhibition of FTO demethylase activity impacts full-length RNA metabolism and blocks 357 packaging 358
We finally sought to determine whether this epitranscriptomic regulation of the HIV-1 full-359 length RNA packaging was a potential therapeutic target for pharmacological intervention. 360
For this, we took advantage of the ester form of meclofenamic acid (MA2), which was shown 361 to specifically interfere with FTO-mediated m 6 A demethylation 27 . Therefore, we analyzed 362
Gag and the full-length RNA in cells treated with DMSO (as a control) or MA2 and observed 363 a reduction in Gag synthesis and the intracellular levels of the full-length RNA indicating that 364 FTO-mediated demethylation is required for proper metabolism of the full-length RNA within 365 the cell (Fig. 5a ). Consistent with a perturbed intracellular full-length RNA metabolism, we 366 observed a decrease in the viral particles released from MA2-treated cells (Fig. 5b) . 367
Strikingly, quantification of the packaged full-length RNA from equal amounts of viral 368 particles indicates that inhibition of FTO activity by MA2 almost abolished packaging (Fig.  369   5c) . 
383
Taking together, these results confirm that FTO-mediated demethylation is critical for HIV-1 384 full-length RNA packaging and this process is a potential target for the design of novel 385 antiretroviral drugs. 386
387
DISCUSSION 388
Assembly of human immunodeficiency virus type-1 particles is a highly regulated process in 389 which the major structural polyprotein Gag together with other viral and cellular components 390 are recruited to the plasma membrane for the release of the viral progeny. The assembly 391 process occurs in multiple steps driven by the different functional domains that compose the 392 Gag precursor. As such, while the nucleopcapsid (NC) domain specifically recruits two copies 393 of the full-length RNA, the matrix (MA) domain allows targeting of the complex to specific 394 plasma membrane micro-domains and the capsid (CA) domain drives Gag multimerization at 395 such sites. Packaging of two copies of full-length RNA by the NC domain of Gag is highly 396 specific and occurs selectively over thousands of cellular and viral RNA species. This 397 selectivity was proposed to be possible by the presence of cis-acting RNA signatures 398 spanning the 5´-UTR and the beginning of the Gag coding region. However, the full-length 399 RNA also serves as mRNA for the synthesis of Gag and Gag-Pol precursors and thus, 400 translation and packaging are expected to be two mutually exclusive processes. Although the 401 adoption of a branched multiple hairpin (BMH) conformation of the 5´-UTR was initially 402
proposed to favor dimerization and packaging over translation [12] [13] [14] , it was later demonstrated 403 that translation of the full-length RNA is under positive selection and thus, not regulated by a 404 conformational switch of the 5´-UTR 18, 19 . Additional structural studies carried out in cells 405 and virions also argued against structural rearrangements as drivers of the transition between 406 translation and packaging of the HIV-1 full-length RNA 16, 17, 28 . Therefore, the mechanism by 407 which Gag selects "packageable" from "translatable" full-length RNA molecules still remains 408 as one of the long-lasting questions in Retrovirology. In this work, we showed that 409 demethylation of two highly conserved adenosine residues within the 5´-UTR is critical for 410 packaging of the HIV-1 full-length RNA. Interestingly, we observed that Gag associates with 411 the RNA demethylase FTO in the nucleus and promotes demethylation of the full-length 412
RNA, suggesting that Gag may drive FTO-mediated demethylation of those RNA molecules 413 that will be used as gRNA to be incorporated into assembling viral particles (Fig. 6 ). This 414 differential epitranscriptomic regulation exerted on the full-length RNA depending on its 415 functions (mRNA or gRNA) may also help to explain the controversies reported in the 416 literature 29 . As such, while the presence of m 6 A favors Gag synthesis through YTHDF 417 proteins acting on the full-length RNA molecules destined to serve as mRNA 21 , the same 418 cytoplasmic m 6 A readers may recognize specific features and drive degradation of the 419 incoming viral RNA early upon infection (i.e., when the full-length RNA acts as gRNA) 22 . 420 Figure 6 Working model for the epitranscriptomic regulation of HIV-1 full-length RNA packaging. The HIV-1 full-length RNA is methylated by METTL3/14 complex in the nucleus (for simplicity, only the presence of m 6 A on the 5´-UTR is shown). However, the structural protein Gag interacts with the m 6 A eraser FTO and drives demethylation of adenosines residues present at the 5´-UTR in a process required for full-length RNA packaging. 
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Further studies are required to elucidate the mechanism by which the binding of YTHDF 427 proteins to m 6 A residues negatively impact full-length RNA metabolism in the absence of 428 translation and whether methylation of the 5´-UTR is involved. In addition, the molecular 429 mechanism by which the presence of m 6 A at the 5´-UTR interferes with full-length RNA 430 packaging also deserves further investigation. One of the most plausible explanations is that 431 recognition of m 6 A residues at the 5´-UTR by reader proteins interferes with Gag binding 432 and/or full-length RNA dimerization. However, it is also possible that the presence of m 6 A 433 itself directly repeals the recruitment of Gag or alters the optimal RNA conformation of the 434 dimerization and/or packaging signal. Indeed, our in vitro structural and dimerization analyses 435 support this last idea as they suggest that the presence of m 6 A affects the folding and 436 dimerization of the 5´-UTR. Of note, although neither A 198 nor A 242 showed a significant 437 reactivity alteration this does not exclude that their modification may have influenced the 438 reactivity of close nucleotides such as G 240 and G 241 . To date no studies have monitored the 439 effect of m 6 A on such a complex structure and here we clearly show that this modification can 440 have not only local but more global effects on RNA folding. Indeed, we observed that the 441 introduction of m 6 A alters dimerization of the 5´-UTR, which could at least partly explain 442 why methylated full-length RNA are not recovered within viral particles. Nevertheless, our 443 experiments using the ΔA 198 /ΔA 242 provirus strongly indicate that these two adenosine 444 residues play a major role in packaging. While A 198 is located within the region 445 complementary to the tRNA Lys3 at the primer binding site (PBS), A 242 is located in the AGGA 446 bulge at the base of the SL1 region and corresponds to a Gag-binding domain previously 447
shown by chemical probing in vitro and in virio as well as by CLIP-seq studies 17, 30, 31 . 448
Further studies are required to fully understand the role of these residues in full-length RNA 449
packaging. 450
In contrast to the simple retrovirus MLV, which segregates its full-length RNA into two 451 separate populations for translation and packaging, the full-length RNA of the human 452 lentivirus HIV-1 was proposed to exist as a single population that can indistinctly serve as 453 mRNA or gRNA. While the presence of two specialized full-length RNA populations 454 supports the lack of an epitranscriptomic regulation of MLV packaging, our data obtained 455 with HIV-1 suggest that its full-length RNA may also exist as two populations with different 456 m 6 A patterns. From these two populations, those molecules lacking m 6 A at the 5´-UTR will 457 be preferentially selected by Gag for packaging ( Fig. 6 ). In this regard, the HCV core protein 458 was also shown to bind preferentially to RNA molecules lacking m 6 A most probably to avoid 459 YTHDF proteins-mediated degradation upon viral entry 32 . Whether the packaging of 460 hypomethylated RNA genomes is a conserved mechanism evolved by RNA viruses to avoid 461 early degradation by cytoplasmic m 6 A readers must be determined. 462
Although the reversibility of adenosine methylation as well as the main target of the RNA 463 demethylase FTO have been recently challenged 26, 33 , we showed that the HIV-1 full-length 464
RNA is a substrate for FTO and this RNA demethylase regulates the incorporation of the viral 465 genome into released viral particles. Interestingly, treatment of HIV-1 producer cells with the 466 specific FTO inhibitor meclofenamic acid resulted in an impairment of full-length RNA 467 metabolism with a potent effect on packaging, confirming the critical role of the demethylase 468 activity of FTO during viral replication. In addition to meclofenamic acid, two small molecules developed by structure-based rational design were recently described as specific 470 inhibitors of FTO m 6 A demethylase activity with the potential to be used as a treatment for 471 adult myeloid leukemia 34 . Therefore, this novel epitranscriptomic mechanism regulating 472 packaging of the HIV-1 full-length RNA could also be exploited as a target for 473 pharmacological intervention. 474
475
METHODS 476
Selective 2´-hydroxyl acylation analyzed by primer extension (SHAPE): The HIV-1 full-477 length RNA 5`-UTR was in vitro transcribed using the T7 RNA polymerase as described 35 . 478
For m 6 A RNAs, ATP was substituted by N 6 -methyl-ATP (Jena Bioscience). RNA was 479 quantified by measurement of the OD 256 using a BioSpec-nano (Shimadzu). RNA integrity 480 was assessed by agarose gel electrophoresis. SHAPE probing was conducted essentially as in 481 17 with minor modifications. Briefly, 6 pmol of in vitro transcribed RNA containing 100% 482 m 6 A or 0% m 6 A were diluted in 24 µl of water, denatured at 80ºC for 2 minutes and ice 483
cooled. After addition of 3 µl of 10X Folding Buffer (HEPES Ph7.5 400 nM, KCl 1M, MgCl 2 484 50 mM), samples were incubated for 10 minutes at room temperature and then 10 minutes at 485 37ºC. Then, the RNA solution was added to 3 µl of 20 mM 1M7 (2mM final) (AEchem 486 Scientific Corporation) or to 3 µl of DMSO (control) and incubated for 6 minutes at 37ºC. 487
RNA was subsequently precipitated in presence of 1 µl of 20 mg/ml of glycogen, 3 µl of 5M 488 sodium acetate, 100 µl of ETOH for 1 hour at -20ºC and then washed with ETOH 70% and 489 resuspended in water. For primer extension, RNA was treated with 1 µl of DMSO and 490 denatured for 3 minutes at 95ºC and cooled at 4ºC. Samples were mixed with 3 µl of 2µM 491 fluorescent primer (D4-5'-TTTCTTTCCCCCTGGCCTT for the probed/control samples and 492 D2-5'-TTTCTTTCCCCCTGGCCTT for the sequencing reaction, Sigma) and incubated for 5 493 minutes at 65ºC, 10 minutes at 35ºC and then 1 minute on ice. 5 µl of Reverse Transcription 494 Mix (10 µl of 10 mM dNTPs and 40 µl of 5X MMLV RT Buffer Promega), 1 µl of 10 mM 495 ddTTP for the sequencing reaction and 1 µl of MMLV Reverse Transcriptase RNAse H 496 minus (Promega) were finally added and the reverse transcription was performed at 35ºC for 497 2 minutes, 42ºC for 30 minutes and 55ºC for 5 minutes. Samples were then ice cooled and 498 precipitated with ETOH for 2 hours. Pellets were resuspended in 40 µl of Sample Loading 499 Solution (Beckman Coulter). Reverse transcription products were resolved on a CEQ-8000 500 sequencer (Beckman Coulter). Electropherograms were analyzed using QuSHAPE 36 . Raw 501 data were processed by excluding the 2% of the highest values and normalizing the remaining 502 values by the mean of the next 8% highest values 37 . The experiments were performed three 503 times and reproducibility was assessed by calculating the standard error of the mean. 504
Secondary structure was drawn using VaRNA 38 . 505 506 Dimerization assay: In vitro transcribed 5`-UTR was serially diluted in 10 mM Tris pH 7, 10 507 mM NaCl, 140 mM KCl to obtain a final concentration ranging from 0 to 1 µM. 20 fmol (2 508 nM final) of radiolabeled RNA was added. Samples were denatured at 95ºC for 3 minutes and 509 then ice cooled. After addition of 1 mM MgCl 2 , RNA was allowed to fold for 30 minutes at 510 37°C. Samples were subsequently chilled on ice, mixed with a 5X native loading buffer 511 (glycerol 20%, xylene cyanol 0.1%, bromophenol blue 0.1%) and loaded on a native 4% 512 acrylamide gel. Samples were run for 1 hour at 100V on 4% native acrylamide mini-gels 513 containing 34 mM Tris, 54 mM HEPES, 0.1 mM EDTA and 2.5 mM MgCl 2 . Dried gels were 514 quantified using a BAS-5000 phosphorimager and MultiGauge 3.0 (Fujifilm). The fraction of 515 dimer was calculated as the ratio "dimer -background" over "dimer + monomer -516 2*background". Data were fitted to Fraction dimer = Bmax*[RNA]/(Kd+[RNA]) using Prism 517 5.02 (GraphPad Software). 518 519 Cell culture, DNA transfection and viral particle purification: HEK293T and HeLa cells 520 were maintained in DMEM (Life technologies) supplemented with 10% FBS (Hyclone) and 521 antibiotics (Hyclone) at 37ºC and 5% CO 2 atmosphere. Cells growing in 6-well plates 522 (2.5x10 5 cells/well) were transfected using linear PEI ∼25000 Da (Polyscience) as described 523 previously 24 . Cells were transfected using a ratio µg DNA/µl PEI of 1/15 and the DNA/PEI 524 mix was incubated for 20 min at room temperature before adding to the cells. For experiments 525 involving the FTO inhibitor, the culture medium was replaced by medium containing 526 dimethyl sulfoxide (DMSO) as a control or 80 µM of an ethyl ester form of meclofenamic 527 acid diluted in DMSO (MA2) prior DNA transfection. For viral particle purification, the 528 supernatant was collected and filtered by passing through a 0.22 µm filter and then 529 ultracentrifugated at 25.000 rpm for 2 hours at 4ºC in a 20% sucrose cushion (prepared 530 previously and stored at 4 ºC). Purified viral particles were resuspended in 100 µl of PBS and 531 stored in aliquots at -80 ºC to then perform anti-CAp24 ELISA (HIV-1) or Western blot 532 (MLV) or RNA extraction. Cells were also collected to perform Western blot and RNA 533 extraction as described in Supplementary Methods. 534 535 m 6 A-seq: Poly(A) RNA was purified from 100 µg of total RNA extracted from HEK293T 536 cells previously transfected with pNL4.3 and pCMV-VSVg. Briefly, total RNA in 500 µl of 537 water was incubated at 65ºC for 10 minutes and incubated with 3 µl of oligo dT-Biotin (dT-B; 538 IDT Technologies) (50 pmol/µl) and 13 µl of SSC Buffer 20X (Santa Cruz Biotechnology) 539 and allowed to cool at room temperature. 600 µg of Dynabeads ™ Streptavidin (60 µl; Thermo 540 Fisher) were washed three times with Buffer SSC 0.5X and resuspended in 100 µl of Buffer 541 SSC 0.5X. Then, the RNA/oligo dT-B mix was incubated with the streptavidin beads at room 542 temperature for 10 minutes in head-over-tail rotation. RNA-beads were washed four times 543 with 300 µl Buffer SSC 0.1X and bound RNA was eluted twice with 100 µl of water. The 544
RNA was precipitated with 10 mM MgCl 2 , 20 µg glycogen (Thermo Fisher) and 2.5 volume 545 of ETOH 100% overnight at -20 ºC and then washed with ETOH 70%. Poly(A) RNA as well 546 as RNA obtained from purified viral particle were fragmented using Fragmentation Reagent 547 (Thermo Fisher). For this, 2 µg of RNA in 9 µl of water was incubated with 1 µl of 548
Fragmentation Buffer 10X for 15 minutes at 70 ºC, then 1 µl of Stop solution was added and 549 incubated on ice. The RNA fragmented was precipitated overnight as described above. 550
Fragmented RNA diluted in 380 µl was heated at 70 ºC for 5 minutes, placed on ice for 3 551 minutes. The denatured RNA was mixed with 1 µl of rRNasin® (Promega), 5 µl VRC, 100 µl 552 of IP Buffer 5X (50 mM Tris-Hcl pH7.4, 750 mM NaCl and 0.5% NP-40) and 5 µl of an anti-553 m 6 A antibody (0,5 mg/mL; Synaptic System #202003) and incubated for 2 hours at 4 ºC with 554 head-over-tail rotation. At the same time, 600 µg of Dynabeads ™ Protein A magnetic beads 555
